Trades on 2 secondary markets

CAMP4

CAMP4 Therapeutics is a clinical-stage RNA-medicines biotechnology company based in Cambridge, Massachusetts, pioneering a new class of antisense oligonucleotide (ASO) therapeutics designed to increase targeted gene expression. Built on the company's RAP Platform (Regulatory RNA Activating Platform)

minimal 9.1 / 100 0 APIs View provider profile →

Company Biotechnology RNA Medicines Antisense Oligonucleotide Gene Expression Drug Discovery

CAMP4 is an API provider whose private shares are listed on 2 secondary markets: Forge Global, Nasdaq Private Market.

Where It Trades

F Forge Global View listing → N Nasdaq Private Market View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.